C‐X‐C Motif Ligand 1 Induces Cell Migration by Upregulating ICAM‐1 Expression by Activating PI3K/Akt and NF‐κB Signaling Pathway in Liver Cancer
Advanced Biology · 2025
DOI: 10.1002/adbi.202400295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2025. Verfasst von Yi-Hsin Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114201, Taiwan. Hauptthemen laut MEDLINE: Liver Neoplasms, Intercellular Adhesion Molecule-1, Cell Movement, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Human hepatocellular carcinoma (HCC) is the most common liver cancer and the third leading cause of cancer‐related deaths worldwide. HCC is a malignant tumor that can lead to intrahepatic and extrahepatic metastases. Intercellular adhesion molecule 1 (ICAM‐1) is involved in cancer metastasis. ICAM‐1 enhances cell‐cell interactions by promoting adhesion and facilitating cell movement within the extracellular matrix. Moreover, ICAM‐1 is more abundant in cancerous hepatocytes than in non‐cancerous ones. Chemokine (C‐X‐C motif) ligand 1 (CXCL1) is found in diverse cancers, including melanoma, breast, lung, pancreatic, colorectal, and prostate. Several studies show a correlation between CXCL1 overexpression and poor prognosis in cancer. CXCL1 has been identified as a candidate gene that could function as a clinically relevant biomarker in HCC. However, the role of CXCL1 in cancer metastasis in HCC is poorly delineated. In this study, Gene Expression Omnibus (GEO) database analysis revealed a positive correlation between CXCL1 level and the progression and metastasis of hepatocellular carcinoma patients. CXCL1 treatment facilitates cell movement through inducing ICAM‐1 expression. The Phosphoinositide 3‐kinase (PI3K)/Akt/Nuclear Factor kappa B (NF‐kB) signaling pathway plays a crucial role in CXCL1‐regulated ICAM‐1 production and cell motility. Thus, CXCL1 represents a promising therapeutic target for treating metastatic hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114201, Taiwan.
- Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114201, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, 100233, Taiwan.
- School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, 110301, Taiwan.
- Translational Medicine Center, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, 111045, Taiwan.
- Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, 404328, Taiwan.
ORCID-Profile: Ju-Fang Liu
Förderung
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Chen, Y. H., Chu, C. C., Liu, J. F., Lai, H. S., & Chen, Y. T. (2025). C‐X‐C Motif Ligand 1 Induces Cell Migration by Upregulating ICAM‐1 Expression by Activating PI3K/Akt and NF‐κB Signaling Pathway in Liver Cancer. Advanced Biology. https://doi.org/10.1002/adbi.202400295
Vancouver
Chen YH, Chu CC, Liu JF, Lai HS, Chen YT. C‐X‐C Motif Ligand 1 Induces Cell Migration by Upregulating ICAM‐1 Expression by Activating PI3K/Akt and NF‐κB Signaling Pathway in Liver Cancer. Advanced Biology. 2025. doi:10.1002/adbi.202400295
BibTeX
@article{Chen2025,
author = {Chen, Yi-Hsin and Chu, Chih-Chun and Liu, Ju-Fang and Lai, Hong-Shiee and Chen, You-Tzung},
title = {C‐X‐C Motif Ligand 1 Induces Cell Migration by Upregulating ICAM‐1 Expression by Activating PI3K/Akt and NF‐κB Signaling Pathway in Liver Cancer},
journal = {Advanced Biology},
year = {2025},
doi = {10.1002/adbi.202400295}
}
EUVIMED